Skin Cancer section

Skin Cancer News & Features

C-reactive protein levels an independent prognostic marker in melanoma

C-reactive protein levels an independent prognostic marker in melanoma

Link with overall, melanoma-specific survival; increase in CRP also linked to disease progression

Radiation plus immunotherapy revs up immune system to better attack melanoma

Treating metastatic melanoma with a combination of radiotherapy and two immunotherapies that target the CTLA4 and PD-1 pathways could produce an optimal response in more patients.

Skin cancer patients resistant to BRAF-inhibitors studied

A new way may have been discovered to more accurately predict the patients likely to respond to genomic-based follow-up therapies, by looking at unique protein patterns in patients with melanoma.

Sun damage predisposes pediatric patients to melanoma

Sun damage predisposes pediatric patients to melanoma

Melanoma in some adolescent and adult patients involve many of the same genetic mutations and would likely respond to the same treatment.

Physicians promote melanoma screening strategies for people at high-risk

Physicians promote melanoma screening strategies for people at high-risk

Melanoma screening strategies may be more feasible by focusing on high-risk populations.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs